Pioglitazone and metformin (Sandoz Inc)
Welcome to the PulseAid listing for the Pioglitazone and metformin drug offered from Sandoz Inc. This Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sandoz Inc |
NON-PROPRIETARY NAME: | Pioglitazone and metformin |
SUBSTANCE NAME: | PIOGLITAZONE HYDROCHLORIDE; METFORMIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-05-02 |
END MARKETING DATE: | 0000-00-00 |
Pioglitazone and metformin HUMAN PRESCRIPTION DRUG Details:
Item Description | Pioglitazone and metformin from Sandoz Inc |
LABELER NAME: | Sandoz Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 15; 500(mg/1; mg/1) |
START MARKETING DATE: | 2013-05-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0781-5626_0bb13b52-8c46-449d-b0a3-ad45ab410f87 |
PRODUCT NDC: | 0781-5626 |
APPLICATION NUMBER: | ANDA091273 |
Other PIOGLITAZONE HYDROCHLORIDE; METFORMIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: